Meklēšana Attēli Maps Play YouTube Ziņas Gmail Disks Vēl »
Ieiet
Grāmatas Grāmatas
" ... new drug. (4) The newness of use of such drug in diagnosing, curing, mitigating, treating, or preventing a disease, or to affect a structure or function of the body, even though such drug is not a new drug when used in another disease or to affect... "
The Code of Federal Regulations of the United States of America - 23. lappuse
1956
Pilnskats - Par šo grāmatu

Code of Federal Regulations: Containing a Codification of Documents of ...

1956 - 1164 lapas
...Stat. 1051, as amended; 21 USC 353) NOTE: Paragraph (f) (1) and (2) of § 1.108 has been transferred to Part 130, as § 130.1 (a). § 1.109 New drugs; definition....201, 52 Stat. 1041, as amended; 21 USC 321) § 1.109a New drugs; exemption from section 505 of the act. A new drug shall not be deemed to be subject to...
Pilnskats - Par šo grāmatu

Code of Federal Regulations: Containing a Codification of Documents of ...

1979 - 1056 lapas
...a new drug when used in another disease or to affect another structure or function of the body. (5) The newness of a dosage, or method or duration of...application, or different condition, is not a new drug. (i) "Animals used only for laboratory research" and "laboratory research animals" mean individual animals...
Pilnskats - Par šo grāmatu

Code of Federal Regulations: Containing a Codification of Documents of ...

1998 - 1120 lapas
...new drug when used in another disease or to affect another structure or func-tion of the body. (5) The newness of a dosage, or method or duration of...application, or different condition, is not a new drug. (1) [Reserved] (j) The term sponsor means the person or agency who assumes responsibility for an Investigation...
Pilnskats - Par šo grāmatu

The Code of Federal Regulations of the United States of America

2002 - 384 lapas
...a new drug when used in another disease or to affect another structure or function of the body. (5) The newness of a dosage, or method or duration of...application, or different condition, is not a new drug. (i) [Reserved] (j) The term sponsor means the person or agency who assumes responsibility for an investigation...
Pilnskats - Par šo grāmatu

Drug Safety: Hearings Before a Subcommittee of the Committee on Government ...

United States. Congress. House. Committee on Government Operations - 1964 - 844 lapas
...a new drug when used in another disease or to affect another structure or function of the body. (5) The newness of a dosage, or method or duration of...application, or different condition, Is not a new drug. § 130.2 Biologies ; products subject to license control. A new drug shall not be deemed to be subject...
Pilnskats - Par šo grāmatu

National Commission on Health Science and Society: Hearings, Ninetieth ...

United States. Congress. Senate. Committee on Government Operations. Subcommittee on Government Research - 1968 - 552 lapas
...a new drug when used in another disease or to affect another structure or function of the body. (5) The newness of a dosage, or method or duration of...application, or different condition, is not a new drug." (Drug Amendments of 1962. ) Specifically, materials introduced into interstate commerce become subject...
Pilnskats - Par šo grāmatu

Use of Advisory Committees by the Food and Drug Administration: Hearings ...

United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee - 1974 - 404 lapas
...Section 310.3(h)(5) states "The newnesss of a drug may arise by reason (among other reasons) of: (5) The newness of a dosage, or method or duration of...application, or different condition, is not a new drug." The Commissioner has reached this tentative conclusion because of the above noted safety issues in...
Pilnskats - Par šo grāmatu

Use of Advisory Committees by the Food and Drug Administration: Hearings ...

United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee - 1974 - 396 lapas
...Section 310.3(h)(5) states "The newnesss of a drug may arise by reason (among other reasons) of: (5) The newness of a dosage, or method or duration of...application, or different condition, is not a new drug." The Commissioner has reached this tentative conclusion because of the above noted safety issues in...
Pilnskats - Par šo grāmatu

Code of Federal Regulations: Containing a Codification of Documents of ...

1976 - 1046 lapas
...a new drug when used in another disease or to affect another structure or function of the body. (5) The newness of a dosage, or method or duration of...application, or different condition, is not a new drug. (i) "Animals used only for laboratory research" and "laboratory research animals" mean individual animals...
Pilnskats - Par šo grāmatu

Drugs in Institutions: Hearings Before the Subcommittee to ..., 3. daļa

United States. Congress. Senate. Committee on the Judiciary. Subcommittee to Investigate Juvenile Delinquency - 1977 - 1374 lapas
...affect another structure or function of the body.32/ 32/ Additionally, 21 CFR S 310.3(h)(5) provides: The newness of a dosage, or method or duration of...application, or different condition, is not a new drug. - 18 The FDA has also acknowledged its responsibility with respect ' to the unapproved use of new drugs...
Pilnskats - Par šo grāmatu




  1. Mana bibliotēka
  2. Palīdzība
  3. Izvērstā grāmatu meklēšana
  4. Lejupielādējiet ePub
  5. Lejupielādēt PDF